265 related articles for article (PubMed ID: 26897385)
1. Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site.
Lee WJ; Moon IJ; Lee SH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2016 Jun; 74(6):1135-43. PubMed ID: 26897385
[TBL] [Abstract][Full Text] [Related]
2. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
[TBL] [Abstract][Full Text] [Related]
3. Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma.
Benner MF; Willemze R
Arch Dermatol; 2009 Dec; 145(12):1399-404. PubMed ID: 20026848
[TBL] [Abstract][Full Text] [Related]
4. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.
Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
[TBL] [Abstract][Full Text] [Related]
5. Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule.
Xue D; Li X; Ren Y; Liu Q; Yen Y; Xue L
Int J Surg Pathol; 2015 Jun; 23(4):333-5. PubMed ID: 25633507
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
Lee WJ; Jung JM; Won CH; Chang SE; Choi JH; Chan Moon K; Park CS; Huh J; Lee MW
J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
[TBL] [Abstract][Full Text] [Related]
7. ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma.
Gupta I; Ramteke P; Narwal A; Sharma MC; Bakhshi S; Mallick S
Am J Dermatopathol; 2022 May; 44(5):376-379. PubMed ID: 35234192
[TBL] [Abstract][Full Text] [Related]
8. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
Kadin ME
Oncology (Williston Park); 2009 Nov; 23(13):1158-64. PubMed ID: 20043465
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
[TBL] [Abstract][Full Text] [Related]
10. ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
Geller S; Canavan TN; Pulitzer M; Moskowitz AJ; Myskowski PL
Int J Dermatol; 2018 May; 57(5):515-520. PubMed ID: 29057463
[TBL] [Abstract][Full Text] [Related]
11. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
Bird JE; Leitenberger JJ; Solomon A; Blauvelt A; Hopkins S
Dermatol Online J; 2012 May; 18(5):5. PubMed ID: 22630575
[TBL] [Abstract][Full Text] [Related]
12. Primary Cutaneous Small Cell Variant of Anaplastic Large Cell Lymphoma: A Case Series and Review of the Literature.
Magro CM; Momtahen S; Kiuru M
Am J Dermatopathol; 2017 Dec; 39(12):877-889. PubMed ID: 28570392
[TBL] [Abstract][Full Text] [Related]
13. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
[TBL] [Abstract][Full Text] [Related]
14. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype.
de Bruin PC; Beljaards RC; van Heerde P; Van Der Valk P; Noorduyn LA; Van Krieken JH; Kluin-Nelemans JC; Willemze R; Meijer CJ
Histopathology; 1993 Aug; 23(2):127-35. PubMed ID: 8406384
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
Xing X; Feldman AL
Adv Anat Pathol; 2015 Jan; 22(1):29-49. PubMed ID: 25461779
[TBL] [Abstract][Full Text] [Related]
16. Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage.
Lee WJ; Won KH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Suh C; Lee MW
Br J Dermatol; 2015 Jul; 173(1):134-45. PubMed ID: 25556641
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous anaplastic large cell lymphomas: a report of 9 cases from Thailand.
Eimpunth S; Sittinamsuwan P; Pattanaprichakul P; Silpa-archa N; Sethabutra P; Chularojanamontri L; Hanamornroongruang S; Mahaisavariya P
J Med Assoc Thai; 2012 Mar; 95(3):437-43. PubMed ID: 22550845
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group.
Melchers RC; Willemze R; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Veraart JCJM; Vermeer MH; Quint KD
Br J Dermatol; 2018 Sep; 179(3):724-731. PubMed ID: 29494757
[TBL] [Abstract][Full Text] [Related]
19. Recurrent ALK-negative anaplastic large T-cell lymphoma presenting as necrotizing vasculitis.
Nambudiri VE; Aboutalebi A; Granter SR; Saavedra A
Am J Dermatopathol; 2013 Jun; 35(4):512-6. PubMed ID: 23291583
[TBL] [Abstract][Full Text] [Related]
20. [Primary cutaneous anaplastic large cell lymphoma: a clinicopathologic analysis of 8 cases].
Wang TT; Wang L; Tang ZR; Cheng JR; Li W; Li FY; Wang WY; Li GD
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):749-53. PubMed ID: 20079014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
